stockrowPhibro Animal Health Corporation
PAHC Healthcare Drug Manufacturers Specialty & Generic
Phibro Animal Health Corporation’s revenue for fiscal 2026 (year ended June 2026) was $1.5 billion, up 17.1% from fiscal 2025.
- Revenue
- +6.29%
- EPS
- +12.3%
- Free cash flow
- +262.1%
- Total debt
- −1.09%
Quarter to September 2026, against a year earlier
Follow PAHC
Alert me
Phibro Animal Health Corporation (PAHC) P/E ratio
As of 5 November 2026, Phibro Animal Health Corporation (PAHC) trades at a P/E ratio of 14.0×. Over the past ten years it has ranged from 8.8× (June 2016) to 374× (September 2024); the current reading is higher than 13% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 20.5× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 12.8× | (40.53%) |
| FY2025 | 21.5× | (92.44%) |
| FY2024 | 284× | 1,579.12% |
| FY2023 | 16.9× | 6.98% |
| FY2022 | 15.8× | (26.64%) |
| FY2021 | 21.6× | (32.73%) |
| FY2020 | 32.0× | 37.79% |
| FY2019 | 23.3× | (20.10%) |
| FY2018 | 29.1× | 28.81% |
| FY2017 | 22.6× | 155.46% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 14.1× | 10.24% |
| Jun 2026 | 12.8× | (46.00%) |
| Mar 2026 | 23.6× | 43.62% |
| Dec 2025 | 16.5× | (32.07%) |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| XERS Xeris Biopharma Holdings, Inc. compare | n/m |
| BCRX BioCryst Pharmaceuticals, Inc. compare | n/m |
| ALVO Alvotech compare | n/m |
| AMPH Amphastar Pharmaceuticals, Inc. compare | 12.3× |
| ANIP ANI Pharmaceuticals, Inc. compare | 13.3× |
| PAHC Phibro Animal Health Corporation | 14.0× |
| CRON Cronos Group Inc. compare | 21.9× |
| ETON Eton Pharmaceuticals, Inc. compare | 26.8× |
| PCRX Pacira BioSciences, Inc. compare | 38.4× |
| Drug Manufacturers Specialty & Generic industry median | 20.5× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)